quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 6, 2026

Stock market today: Dow closes above 50,000 for the first time as stocks soar to cap volatile week

View original at finance.yahoo.com
Stock market today: Dow closes above 50,000 for the first time as stocks soar to cap volatile week US stocks rebounded on Friday from a weeklong tech bruising as Wall Street reassessed worries about the impact of AI disruption and the risks of hefty Big Tech spending…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • FDA will take swift action against companies mass-marketing illegal copycat drugs

    80% confidence

  • All Big Tech AI capex spending is going to Nvidia

    80% confidence

  • Caterpillar has become the ultimate story stock touching AI/Power, infrastructure, and critical minerals themes

    80% confidence

  • Novo Nordisk will take legal and regulatory action to protect patients, IP, and drug approval framework integrity

    80% confidence

  • Fed interest rates are in neutral range with higher bar for cuts

    80% confidence

  • Investors will likely start giving credit to companies capturing profits from Big Tech AI investments

    80% confidence

  • AI data centers have insatiable demand for fiber

    80% confidence

  • Lumen's balance sheet is now really strong after being in serious financial trouble two years ago

    80% confidence

Data points we hold from this source

Dow Jones Industrial Average · weekly change2.5 percent
Dow Jones Industrial Average · daily percent change2.47 percent

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Stock market today: Dow closes above 50,000 for the first time as stocks soar to cap volatile week — Source | Via News | pt.VIA.NEWS